Obesity

Obesity Sleep Health Sleep Quality Walking Arrhythmia Obesity Inflammation Walking Lifestyle Changes Observational Studies

3 ARTICLES

last mo.

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies

The collaboration aims to develop four GPCR-targeted small-molecule treatments, diversifying Novo Nordisk’s portfolio amid rising competition from Eli Lilly.

9 ARTICLES

2mo ago

Brisk Walking Linked to 43% Lower Risk of Heart Rhythm Abnormalities

4 ARTICLES

3mo ago

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

5 ARTICLES

3mo ago

Study Shows One Sleepless Night Triggers Immune Changes Linked to Inflammation